Get Started

INMB

INmune Bio (INMB)

INmune Bio Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INMB

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Date	Time	Source	Headline	Symbol	Company
08/22/2019	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INMB	INmune Bio Inc
08/21/2019	4:36PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INMB	INmune Bio Inc
08/21/2019	4:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INMB	INmune Bio Inc
08/16/2019	4:40PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INMB	INmune Bio Inc
08/15/2019	4:33PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
08/13/2019	4:37PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
08/12/2019	5:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INMB	INmune Bio Inc
08/12/2019	9:01AM	GlobeNewswire Inc.	INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update	NASDAQ:INMB	INmune Bio Inc
08/09/2019	4:59PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INMB	INmune Bio Inc
08/09/2019	4:39PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
08/09/2019	4:34PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INMB	INmune Bio Inc
08/08/2019	8:30AM	GlobeNewswire Inc.	INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member	NASDAQ:INMB	INmune Bio Inc
08/07/2019	4:32PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
08/05/2019	9:01AM	GlobeNewswire Inc.	INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer	NASDAQ:INMB	INmune Bio Inc
08/01/2019	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
08/01/2019	9:01AM	GlobeNewswire Inc.	INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit	NASDAQ:INMB	INmune Bio Inc
07/30/2019	4:58PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
07/29/2019	4:06PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:INMB	INmune Bio Inc
07/29/2019	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:INMB	INmune Bio Inc
07/26/2019	4:40PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:INMB	INmune Bio Inc
07/25/2019	9:01AM	GlobeNewswire Inc.	INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019	NASDAQ:INMB	INmune Bio Inc
07/18/2019	2:51PM	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:INMB	INmune Bio Inc
07/09/2019	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
07/03/2019	5:00PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
07/03/2019	1:03PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:INMB	INmune Bio Inc
07/03/2019	9:01AM	GlobeNewswire Inc.	INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease	NASDAQ:INMB	INmune Bio Inc
07/03/2019	6:12AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:INMB	INmune Bio Inc
06/28/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc
06/27/2019	9:03AM	GlobeNewswire Inc.	INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE	NASDAQ:INMB	INmune Bio Inc
06/26/2019	1:56PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INMB	INmune Bio Inc